Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort studyResearch in context
Summary: Background: Oral tauroursodeoxycholic acid (TUDCA) is a commercial drug currently tested in patients with amyotrophic lateral sclerosis (ALS) both singly and combined with sodium phenylbutyrate. This retrospective study aimed to investigate, in a real-world setting, whether TUDCA had an im...
Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Elsevier
2023-11-01
|
Серии: | EClinicalMedicine |
Предметы: | |
Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S2589537023004339 |